Retail conglomerate Walmart announced the creation of its own brand of analog insulin to offer diabetics a more affordable option than the expensive brand name versions. “We know many people with ...

As Walmart touts its efforts to make healthcare more affordable, the company struck a deal with drugmaker Novo Nordisk to offer a discounted version of its analog fast-acting insulin. Walmart plans to ...

Walmart has announced it will launch its own brand of insulin, aiming to cut costs for diabetics reliant on the expensive drug. The price of insulin has skyrocketed in recent years, making it ...

Walmart Inc (NYSE: WMT) announced Tuesday it will begin offering private-label insulin this summer at a much lower price than branded versions of the life-saving diabetes drug. The retailer said it is ...

The company is releasing insulin vials and pens under its ReliOn house brand. They'll show up in Walmart pharmacies this week. Jessica was a writer on the Wellness team, with a focus on health ...

Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...

For years, advocates of healthcare reform have been saying the market for prescription drugs is rigged, with powerful pharmaceutical companies setting prices at unreasonably high levels. Drug ...

Walmart announced Tuesday it will start selling private-label insulin this summer at a much lower price for the lifesaving diabetes drug than branded varieties in vials and pens. The new brand, called ...

Walmart Inc. has added a new insulin product to its more affordable private-label brand for diabetes management, the company said Tuesday. ReliOn NovoLog Mix 70/30 combines a fast-acting insulin to ...

Walmart has launched the first private brand analog insulin with a steep discount saving 59% and 75% respectively on the current cash price of branded insulin products when not using insurance. It is ...

WASHINGTON — Walmart on Tuesday announced the launch of the first-ever private brand of analog insulin, promising a lower-cost option on a crucial drug used by millions of diabetes patients. The ...